和血明目片治疗球结膜下出血50例

Clinical observation of 50 cases of subconjunctival hemorrhage treated with Hexuemingmu tablets

目的:观察和血明目片治疗球结膜下出血的临床疗效,寻求缩短球结膜下出血病程、提高疗效的治疗方法。方法:将就诊的82例球结膜下出血患者随机分成两组,和血明目片组(50例50眼):口服和血明目片5片,每日3次;维生素C组(32例32眼):口服维生素C0.2g每日3次,并进行临床观察。结果:随访1mo,和血明目片组治愈40例,7例有效,3例无效,总有效(治愈+有效)率为94%;维生素C组治愈16例,9例有效,7例无效,总有效(治愈+有效)率78%。两组有效率差异有统计学意义(P=0.015<0.05)。结论:和血明目片治疗球结膜下出血疗效显著,可明显缩短病程,方法简单,未发现不良反应,安全可靠,疗效确切,值得在临床治疗中应用推广。

AIM： To observe the clinical effect of Hexuemingmu tablets for the treatment of subconjunctival hemorrhage, and to seek a treatment which can shorten the course of disease and improve the efficacy. o METHODS： Eighty-two （82 eyes） patients randomly received either Hexuemingmu tablets treatment （ n = 50 cases） or Vitamin C treatment （n = 32 cases）. Patients were treated with Hexuemingmu tablets （5 tablets） or Vitamin C （0. 2g） by oral drugs （3 times a day） respectively. They were clinical observed. RESULTS： After 1 month, among 50 patients treated with Hexuemingmu tablets, 40 patients were cured, 7 patients were improved and 3 patients were invalid. The total effective rate was 94% （47/50）. While in Vitamin C group, 32 patients were treated, 16 patients were cured, 9 patients were improved, and 7 patients were invalid. The total effective rate was 78% （25/32）. There was a significant statistical difference between the two groups （ P= 0.015〈0.05）. CONCLUSION： It is effective, easy and safe to use Hexuemingmu tablets for the treatment of subconjunctival hemorrhage. It is worthy to be popularized in clinical treatment.